Vasomune Therapeutics Appoints Douglas A. Hamilton as President and Chief Executive Officer
09. Oktober 2018 08:00 ET
|
Vasomune Therapeutics
Toronto, ON, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Vasomune Therapeutics, a leading biotechnology company developing therapeutics targeting vascular dysfunction and inflammation, announced today Douglas...